Published in

American Association for the Advancement of Science, Science, 6529(371), 2021

DOI: 10.1126/science.abf4063

Links

Tools

Export citation

Search in Google Scholar

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Variable memoryImmune memory against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) helps to determine protection against reinfection, disease risk, and vaccine efficacy. Using 188 human cases across the range of severity of COVID-19, Danet al.analyzed cross-sectional data describing the dynamics of SARS-CoV-2 memory B cells, CD8+T cells, and CD4+T cells for more than 6 months after infection. The authors found a high degree of heterogeneity in the magnitude of adaptive immune responses that persisted into the immune memory phase to the virus. However, immune memory in three immunological compartments remained measurable in greater than 90% of subjects for more than 5 months after infection. Despite the heterogeneity of immune responses, these results show that durable immunity against secondary COVID-19 disease is a possibility for most individuals.Science, this issue p.eabf4063